primary

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society…

5 days ago

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine

Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to…

6 days ago

Global Active Cyber Insurance Leader Coalition Launches in France

With Capacity Provided by Allianz, Active Insurance is Now Available to Businesses up to €1 Billion in Revenue on a…

2 weeks ago

C2N Announces Major Global Expansion, Adds Six New International Partners

PrecivityAD2™ blood test now available in over seven additional countries with primary focus on regions with inadequate PET infrastructureST. LOUIS--(BUSINESS…

4 weeks ago

Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis

KOLKATA, India, July 28, 2025 /PRNewswire/ -- In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was…

1 month ago

FDA Approves Apellis EMPAVELI (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of…

1 month ago

Game-Changing HSA Reforms Just PassedHeres What It Means for Healthcare

Landmark legislation enables HSA use with Bronze/Catastrophic ACA plans, telehealth, and Direct Primary Care—bringing healthcare savings into the modern era.SAN…

2 months ago

IDEX Biometrics ASA: Mandatory notification of trades – 19 June 2025

Reference is made to the stock exchange notice from IDEX Biometrics ASA on 15 June 2025 regarding the share issue…

3 months ago

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

CLEVELAND, June 13, 2025 /PRNewswire/ -- Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in…

3 months ago